tv The Claman Countdown FOX Business December 17, 2020 3:00pm-4:00pm EST
personally, i have become a rollerblader during quarantine. maybe dick's sporting goods as well. we definitely are going to see continued outdoor interest and people exploring our natural parks. it's absolutely wonderful. charles: dick's, dks has been a super-hot stock. thank you very much. speaking of super-hot, the market's up, pockets of the market, though, absolutely sizzling including bitcoin, as i hand it over to liz claman. liz: yeah. i'm touching the ticker and it's burning up. all right. we've got this breaking right now. if you own, what am i doing? all right. if you own google shares or have ever googled anything, a major shot has been fired by 38 states straight at the company's heart of search. the stock right now is responding, down 1%. we will get you more on that. we've also got two major fuzzy pieces of the market puzzle that could come into much sharper focus within the next 59 minutes.
we now know the race to craft a relief bill for americans hanging by a thread will spill over into the weekend. we thought we had the details of what's in and what's out but there is now a new sticking point that has popped up. we are taking you live into d.c. and the vote that could unleash millions more doses of covid vaccines in the u.s. is about to take place as well. this time it swirls around biotech firm moderna. that's unfolding at this hour. moderna taking the spotlight in the market today. we've got pfizer and biontech trailing behind but moderna at the moment is moving higher by five. when i say trailing, i sniemean the green because pfizer is up 5.7%. in just a half hour, we have one of the doctors who led the moderna trial. what he says may define whether you want moderna's or pfizer's vaccine and who should not take either one. in a first on fox business
interview, the branding genius behind one of the most highly anticipated debuts of the year, rohan oza, the man with the midas touch who brought you vitamin water, chef's cut and kombucha launching his first spac. what will it get him to write that blank check that could catapult one company to superstardom in the publicly traded world? first, a fox business alert. a stumbling block has reemerged in the race to pass a pandemic relief package, just as cries for help from struggling americans become more desperate. the latest jobless claims report hitting a three-month high coming in at 885,000 new applications. that's 85,000 more than estimates. stack that on top of yesterday's retail sales number for the month of november, a fall of 1.1%. that far outpaces the much smaller expectation of a .3% drop and we are looking at some serious pressure on congress to get something done yesterday.
to the white house and blake burman. blake, we thought this thing was really coming into focus but now we've got pat toomey of pennsylvania making a demand? reporter: there are demands from all different corners in washington, liz, as to what should or shouldn't be included in this potential covid relief bill and one of them comes from the republican senator from pennsylvania, pat toomey. you're right. he now wants language included in this potential deal that would allow for a wind-down of the fed's abilities to set up credit lending facilities. that would run contrary to the warning that the fed chair jay powell gave just yesterday. >> now that we can kind of see the light at the end of the tunnel, it would be bad to see, you know, people losing their business, their life's work in many cases or even generations' worth of work because they couldn't last another few months. reporter: the package that is being discussed is roughly $900 billion, getting close to the finish line. we have an idea of some of the major top lines of what would be involved. that includes a round of direct payments, $600 to individuals,
more if you have children. $300 a week for the federal plus-up of unemployment insurance benefits, more than $300 billion in help for small businesses, the overwhelming majority of that for reauthorization of the ppp, along with money specifically designated for vaccine distribution. now, this would be a massive package by historical standards, but also well short of the $3.4 trillion that democrats had once sought and the $1.9 trillion the white house had once proposed. the senate majority leader saying today that unspent money would go to fund the bill. >> we intend to repurpose more than $400 billion in unspent funds which we already allocated in the cares act. it turned out these funds did not need to be capped to restore basic stability to our economy. it's time we put that money to urgent use. reporter: it is possible that there is a deal that would come together at some point over the next 24-48 hours or so here at
the white house. they are optimistic with that time frame. there is also optimism on the hill but we also heard from mitch mcconnell today suggested this very well could go into the weekend. liz: yeah. you know, i don't know if you saw axios this morning. i read their morning note. the first line was regarding stimulus, stop me if you've heard this before. reporter: the last five, six, seven months, whatever it's been, right? liz: indeed. indeed. blake burman live at the white house. okay. let's just say mitch mcconnell and nancy pelosi heard jay powell's warning and complete the stimulus plan sometime this weekend. that would give the federal reserve chief and many americans exactly what they want for christmas. then the fda advisory panel reviewing the safety and efficacy of moderna's vaccine as we speak, it could get approval as early as this evening plus we are seeing bitcoin making new records nearly every hour,
topping $23,000 per coin and coin base, by the way, just now filing confidentially for an ipo. just when you think four of the most important presents are already under the tree, what are investors missing? to our floor show. tom hayes and chris robinson. tom, what is missing from this picture? there's always something, isn't there? what are you buying or even selling? >> yeah. well, liz, as you said, fed's going to keep short rates low to 2023, they will keep the market at $120 billion of treasury and mortgage-backed securities per month, check. congress is going to do a $900 billion bridge to get us to full vaccination by q2. you've got global pent-up demand from $20 trillion of fiscal and monetary support around the world, and now you've got a bunch of top colors coming out because sentiment has risen and saying we must correct because we are seeing pockets of euphoria in the market. i think there will be no grinch this year. if you want to worry about the grinch, wait until q1.
certainly after 65% rise off the lows in march, we are going to consolidate some gains. that should be used to purchase versus sell, if you remember in 2009 we had a similar gain off the lows. big corrections in 2010 and 2011. if you sold, you missed out on many years of gains. also, bank of america came out with their survey on tuesday, monthly global fund manager survey. they found yield curves steepen i ing, at their highest level in history. the last three times yield curve steepening expectations were this high were november of 2016, august 2013 and late 2008. all three times were the perfect times to buy banks, because net interest margins increased, they are going to release a lot of reserves and that's one of our key calls moving forward. wells fargo is up 43.6% in the last seven weeks. we have been talking to your viewers about that for a number of months. and the contrarian trades they
put out were actually long energy and short tech. you mentioned the antitrust head winds. these are echoes of microsoft 20 years ago. it slowed them down and -- liz: let me just jump in here. i do want to jump in here, because maybe, chris, that's what we are missing, perhaps. that is look, the breaking news in the last hour, 38 attorneys general across the united states have now filed suit and they are blaming google for monopolizing search. that's really very much a huge heart of the business. we can look at the stock, not only that, but now it looks like obviously facebook is under attack. facebook is under attack and who knows what they are going to charge amazon and apple with at some point for kind of dominating each of their areas. so is that sort of the be careful here, because that's been the leadership area? >> you always have to worry about that. the time to worry about a
correction is when everybody is looking up and nobody's looking down, right? really, over the past three, four weeks, i don't know how many people i have heard, experts in the field, saying we are definitely going to have 10% next year, 10%. well, that's great. when everybody is thinking the same thing, though, that gives me pause for worry. that would be my concern. everybody also thinks that it's going to be a good thing if they do do any sort of antitrust breaking up, because then we're like we can't wait to buy all the parts if they break up these big tech companies. so everybody, it's amazing to watch the emotion of this market, because the exact same people that were, you know, some were in tears back in march and april, now they are pounding on their chests like tarzan saying i can't wait for 2021, it's all gravy. sooner or later, we will have a pullback and i think your first guest was correct. those are probably dips you want to look for, but it does feel like it's getting kind of frothy at the year end. people are buying things they haven't owned before. you've got, you know, we get a
$50 print in crude oil. how long before people start talking about $100 oil again? if we get, you know, things like that. you are starting to see that. you are starting to see big news in commodity prices. cotton has gone up 45% since the lows. soybeans, same thing. 45%. tremendous rallies and what's fueling that also, the weaker dollar. nobody's talking about that today. we made a new three and a half year low. we go another couple pennies lower we will be at six-year lows in the dollar. that's back to where we were in 2018. so there's a lot of -- it's always good when the markets are rallying like this but i would caution everybody who is very, very, very bullish right now. again, i would be more worried about some sort of unseen correction. that's always a thing we don't expect coming that get us. liz: yeah. you want to be cautious when everybody's looking up and that's when you want to look down and make sure where are the potholes. great to see you both. tom hayes, chris robinson.
the dow jones industrials up 122 points. fox business alert. time now for your pop stocks. pop and drop here. airport massage chain turned rapid covid testing site company xpresspa fumbling a 30% gain earlier within just a few hours. the stock initially soared like a jet on news that it struck a new partnership with united airlines to offer covid testing services at newark international and denver international airports beginning this monday. but just before 1:00 p.m., that's the ceo showing us exclusively one of their testing areas, at newark, just before 1:00 p.m., shares completely reversed after the company issued 24.5 million of its common shares and short-term warrants for direct offering. investors hated that. now they are down 5%. you can see airline, united airlines down about .25%. let's flip it over to chewy. chewy rallying in this final hour to new highs after
receiving bull calls from two wall street firms. first needham calling the everything for pets e-commerce player a top pick with strong growth potential next year. stock loves that. it's up 6%. meanwhile, rbc confident that chewy will continue to ride the covid tailwinds, which they say will boost sales long-term. but here comes competitor bark box. not to be confused with birch box. bark box looking to capitalize on the pandemic-fueled spending on pet products. the monthly subscription startup set to go public via spac in a $1.6 billion deal with northern star acquisition corporation. we will be watching for that one. and streaming media player roku spiking to all-time highs as it officially opens its tv screens to hbo max after a six-month standoff. it finally struck a deal with warner streaming offering which can now get in front of roku's more than 100 million users.
or 200 million eyeballs. roku also seeing a street high price target, benchmark raised the call on shares to $410 from $300. the stock right now at $329.79. at & t moving in the reverse, down 2%. all right. at this hour yesterday, remember we showed you how restaurants across new york city were rushing to drag anything that wasn't nailed down in their outdoor setups ahead of the massive snowstorm? coming up, kristina is back to show us what things look like today after a near foot of snow and what business owners are saying right now as they dig out from the winter blast, and at the same time, try to keep from financially drowning in this pandemic. closing bell, we are 47 minutes away. "the claman countdown" is coming right back. to support a strong immune system,
your body needs routine. centrum helps your immune defenses every day, with vitamin c, d and zinc. season, after season. ace your immune support, with centrum. ♪ may your holidays glow bright and all your dreams take flight. visit your local mercedes-benz dealer today for exceptional lease and financing offers at the mercedes-benz winter event.
slammed into much of the northeast, dumping feet of snow and sleet. new york's central park got hammered by 10 inches of the white stuff. yet another blow to a fragile restaurant industry. let's now head to chinatown where kristina partsinevelos, who showed us restaurant row in midtown yesterday, is now surveying the situation post-snowstorm. what do you see there? reporter: right now, i came to chinatown, actually we moved to little italy because the streets are so narrow here, and most are one-way. often on the weekends they close for pedestrians but just wanted to show you the proximity and how difficult it is for so many of these restaurants given the level of snow, more specifically, at this restaurant here, they haven't even replaced the plastic awning just above my head over here because they have to deal with insurance. i spoke to one of the servants who said it would be really expensive and it would take time for the company to come back here and fit it. you have overall just a drop in spending. indoor dining is banned here in
new york. outdoor dining was suspended but it's back on and yet spending over the past three months from september to november has dropped about 4.5%, a dramatic drop. i spoke to a server who says he's only working four days a week because of how difficult it's been for him. listen in. >> we need to survive. this is hard for us. who is going to sit outside? a couple of people are there for coffee because not for food. the food is going to be cold right away. who is going to sit outside like this, you know? reporter: in new york, indoor dining is closed but there's a different scenario out in california. that's because a judge extended an order to open strip clubs in san diego. this comes after those restrictions for businesses as well as houses of worship in san diego and the reason is he established any type of building with restaurant services can stay open and that includes strip joints. may not be the case for new york
because now mayor deblasio says the hospitalization cases could be increasing and that could mean a lockdown as early as christmas. but i want to end on a positive note. look at these troopers. they came out, it's cold and they are outdoor dining. back to you. liz: yay. support your local restaurants, absolutely. that is so good to see. kristina, thank you very much. yeah. strip joints. okay. figure that one out. checkmate. the newest season of "the crown" knocking the queen's gambit out of the top spot in nielsen's latest read of the top shows. the two netflix shows outdoing all streamers for the week ending november 22nd and netflix is moving yet again to the upside, up 1.33%, now standing at $532. from the original king of content to the reigning king of branding. shark tank's rohan oza, who helped bring john legend and
justin timberlake to 5pei and he's looking to take a new company public via spac. he is here first on fox business. he's going to reveal exactly what he is looking for. closing bell ringing in 40 minutes. we will also get you an update on that fda advisory panel happening right now. they should be very close to approving moderna's vaccine. we'll be right back. state-of-the-art but dependable. in other words, you want a hybrid. so do telcos. that's why they're going hybrid with ibm. a hybrid cloud approach with watson ai helps them roll out new innovations anywhere without losing speed. from telco to transportation, businesses are going with a smarter hybrid cloud, using the tools, platform and expertise of ibm. good work little buddy. ♪ ♪
liz: the man dubbed the hollywood brandfather is ready for his next billion dollar idea. rohan oza is entering the spac world. last week, he took his special purpose acquisition or blank check company public on the nasdaq. this is his very first spac. he's the guy behind brands from kambucha to vitamin water to
chef's cut, beef jerky, chicken jerky. he's got a blank check and he's looking to buy the next big health and wellness brand. joining us first on fox business to talk about it is rohan oza. what are you looking for to spend your money on? [ laughter ] >> we're super-excited. this was a joint venture between me and brett thomas, you like him better than me, and also the guys at human co, jason and ross, we sort of joined forces because we thought that together, we could give entrepreneurs and ceos from health and wellness companies more value added because as you
know, at cavu we love to build brands. for us, we can bring our whole value add, marketing, influencers, celebrities, et cetera and they bring all the public marketing because they were previously in this sort of hedge fund world and jason also co-founded a company that's growing at a rapid clip. merging the forces is just going to make us much stronger as we go out to find what we call the brand of tomorrow. liz: the brand of tomorrow, but can we drill down a little bit. do you think it will be a drink like you have done already, vitamin water, bai, will it be food, for example, because you also found really big success there as well. what specifically would catch your eye to spend your money on? >> it's really all of the above, liz. give me one second, i will explain what i mean by that.
what covid has done has really accelerated human behavior in the world in the last nine months. if you think about it, in january, i think probably 6%, 7% of people are buying their groceries online. now 45% plus are doing it. if you are in california or new york it's probably north of that. people just want to get back to being normal, and normal has been redefined. obviously the vaccine's a massive component of that. but beyond that, people want their bodies to be more bulletproof. you want to go to the movies, want to go out with friends, you want to go to dinner, you want to travel, and you don't want your body to let you down. the way that really comes about is kind of what goes in your body, you said it, food and beverage, and we've got a bunch of those brands that we are part of, personal care, what you put on your body and how you treat your body, fitness, you see what peloton has done in the market.
you are seeing what mirror just sold for. all of the above, as well as wellness, you see what karma is doing. and the final one is how do you monitor all of this. groups like apple watch track how you perform. that's the full landscape of health and wellness we are looking at because it's how people are going to start feeling better about themselves and managing their personal health. this is the most important engine we have been given. liz: is there a timetable for this? you went public last week and right now, by the way, the stock is moving higher by about a percent. that's good news. listen to you. you are the king midas. it's above i believe $11. can we pull that up at the moment? >> not bad. [ speaking simultaneously ] liz: is there a timetable?
when do you expect to be really kind of finding the company you would like to wrap these millions around? >> well, it could be billions, by the way. we are going big here. we want to find great brands and there are so many out there. we have begun to search, as soon as the spac was done, we are now looking at finding companies and you know, one of the things brett always said, there's a bit of a dislocation in the market where you and i both know everyone wants to feel better about themselves but there has not historically been the opportunity for public market investors to really go and invest their money into either the brand they use, the brand they believe in and the health and wellness brand of tomorrow. that's why you see beyond meat getting what it's getting, you are seeing peloton's valuation. oakley his going to come out net year at a monster valuation. the spac thing works because it gives them access to really brands that are not out there in the public sector that are going
to be the brand of tomorrow. that's what we're looking for. liz: well, you are the 237th of this year. it's pretty impressive. all that has been happening with spacs, we are watching it. please come back -- >> i think the difference is the value added we bring. that's going to be the x factor, in my opinion. there are too many spacs and the spacs that are going to win are the ones that bring value. liz: excellent point. come back when you make your pick. thank you so much. >> thank you. liz: rohan oza live from florida. with just over a month until the biden administration is sworn in, what will the future of all capitalism, you know, people like rohan launching spacs and the stock market and you know, the freedom to start businesses, we potentially could face new regulations. charles payne hosts a virtual town hall on how this may
reshape how the free markets operate, called the future of capitalism, january 13th. 2:00 p.m. eastern time. let's get to this. a live picture right now, if we can, to dip into that fda advisory panel where they are scrutinizing moderna's covid-19 vaccine data. the pharma giant's potentially hours if not minutes away from receiving emergency use authorization of i sats covid vaccine. coming up, the doctor who headed up the moderna trials at rutgers universities. he's currently working with j & j on its covid preventive. he's about to tell you which vaccine you should take. closing bell ringing in 28 minutes. we'll be right back. we are on track for records at the nasdaq, the russell and more. ♪
liz: take a look at this live picture. we will soon hear what comes out of this virtual fda advisory committee meeting, where they are currently at this moment vetting the second covid-19 drug the world is waiting for. moder moderna's vaccine. the committee is poring over the data carefully before making a recommendation to the agency about whether to grant emergency use authorization. we are honored to bring in dr. reynold panatierre who is overseeing the clinical trial of the moderna vaccine at rutgers university. he is professor of medicine at robert wood johnson medical school and is also working as an adviser to the germ exchange traded fund which has moderna as its top holding. welcome, doctor. can you give us the sense right now of what you expect to come out of this meeting? >> well, this is truly a historic and monumental task.
the approval of a second mrna vaccine. the data that the advisory board had looked at was really quite promising for efficacy and safety, and i could only imagine that the fda will approve this swiftly. liz: okay. that's a big statement. you do expect approval. let's talk about how it actually works. you mentioned mrna. for those who don't know, this is the same as how the pfizer vaccine works where scientists are able to repurpose a tiny particle of the virus and isolate that and then be able to work on that to inject it into humans and then it takes over cells and then begins to replicate and fight it off, correct? >> yes that's correct. it's actually the precursor for a protein. this is a really unique platform. it's never been used before. we heard pfizer has implemented it and moderna has also
implemented it. it is the precursor protein of a virus. it gets into the cells, the cell then produce the viral protein, shed it. there is no virus, but it stimulates the immune system to fight the viral invasion. it's really a remarkable and unique approach to vaccination. liz: i understand that about 16% of those who got the shot during the trial did experience adverse reaction. now, that is, of course, for those who understand these things, the immune response suddenly kicking in, it's called reactogennicity. people are worried when they see severe reaction, even if it is a small percentage, they are wondering should i do it, i have a shrimp allergy or i suffer from asthma. >> yeah. that's a very good point. i think we have to look at risk/benefit ratios.
you mentioned 16% of individuals actually had an adverse effect. none of these were serious, by the way. none of these were serious adverse effects. but if turn it over, that is 84% of people have no consequence to this. the benefit is the protection, is the protection against the virus. so risk/benefit ratio. now, the adverse effect that we talk about are muscle aches, pains, maybe low grade fever. why is that happening? it's happening because a viral protein is being produced and the body identifies the foreign protein and then generates an immune response. you can't get the virus from this vaccine. it is stimulating the body's machinery to fight the infection. some people will experience a little bit of local swelling and redness and maybe some muscle
aches but that dissipates quite quickly. liz: you are also the principal investigator for the j & j, the johnson & johnson covid-19 vaccine, so people will, god willing, be able to have all three of these choices. what should they be taking into account as they look at the pfizer vaccine, moderna and j & j? >> great question. which one is the vaccine for me. there's one answer. the one you can get. there is evidence that efficacy is comparable between the moderna and pfizer vaccines. they are very comparable. we would hope the traditional platform for vaccine development that j & j is producing will have comparable efficacy. we don't know that yet. that study will have closed for recruitment today and probably will read out in the next 60
days. so we are looking forward to having a third vaccine but when i am asked by my patients and my colleagues which one should i have, it's the one you can get. because the sooner you get vaccinated, the sooner you will have protection against the virus. liz: doctor, to you and your team, we thank you for all the work that you are doing, all three of these names in the stock market are moving higher but moderna really charging higher by about 5.8%. good luck to you, sir. please join us again. >> thank you so much. have a good day. liz: you, too. electric vehicle behemoth tesla just days away from joining the s&p 500. you knew that. but why is tomorrow the day investors should be watching? forget monday, when it happens. charlie gasparino has this important detail for us next. in case you missed it, the co-founder and ceo of orka
securities joins my everyone talks to liz podcast this week, talking about his take on the recent solarwinds hack and his time training an israeli unit 8200, the elite area where they learned a most unique way to solve problems without the presence of technology or google. he's going to describe how they put them in a room, they gave them a problem and they teach them how to solve it. creative thinking led him to start orca security where he aims to fix the fundamental cloud security problem. listen to everyone talks to liz on spotify, google, wherever you get your podcasts. closing bell ringing in 17 minutes. guess what? it's the s&p that's on record as well. same with the dow. four records could be happening in 16 and a half minutes. don't go away. to all the businesses that helped us
and for the extra pump of caramel. thank you for the good food... and the good karma. thank you for all the deliveries... especially this one. you've reminded us that no matter what, we can always find a way to bounce forward. so thank you, to our customers and to businesses everywhere, from all of us at comcast business.
liz: tesla spiking right now. tesla founder and ceo elon musk one of the rare people whose fortune has not only risen during this very tumultuous year, it's catapulted him to the second richest in the world. his ev giant stock soaring more than 674% since just january 1st. while, yes, tesla joins the s&p on monday, there is a way more important day, actually it's tomorrow, just 24 hours from getting our first inkling of what tesla's weighting will be when it becomes part of the s&p. why does that matter? charlie gasparino joins us now with what insiders at tesla are saying on the street as well about right now and the road ahead. charlie: yeah, as you know,
tomorrow is the big day because in the weighting on the s&p, it's the friday close price that is reflected in that weighting. so tomorrow, whatever it closes at will be a big part of, you know, exactly how much it's weighted, the s&p. we should point out that it's not as big of a weighting as apple. i think that's like 5% of the s&p. it's going to be pretty big. it's probably the most valuable stock, i'm getting this from barron's and others, to ever be added to the s&p right now, and you know, listen, it could be a wild ride here in the sense that, you know, the indexes reflect the weighting. that's fine. but fund managers basically have benchmarks. the benchmarks are the fund managers, the s&p. so fund managers have to figure out how much are they going to put in, how much are they going to buy or sell of this stock, and you know, you can make a bearish and bullish short-term case either way. does it trade off following the
inclusion, does it continue to trade up. some of the options trading suggest it's going up. it's going up today, as you know. it's kind of interesting. long term, though, is less of a sort of technical how the stock is doing now and why because of the addition to the s&p but it's more about the fundamentals of the company, and there are two narratives still out there. there's the narrative known by many shorts that say the company is not, does not make money, it is trading way above -- it's fighting above its weight, so to speak. it doesn't make money, there's competition from ev -- from traditional auto makers in the ev space. elon musk -- liz: it's profitable. that's why it's allowed -- charlie: it's barely profitable. it's not as profitable as some of these others. that's the bearish case. the bullish case is that, and i'm getting this from a lot of bankers that bank the stock, that think it's the next big thing, they are expanding all over the place.
elon musk has got his act together. there is huge growth in china. i mean, if you think of an electric vehicle, i'm not thinking of any of the other competitors, i'm thinking tesla. it's actually a good product. and it's first in. once you are first in, you've got some running room and the market is valuing it on its future, not on the past. take your pick. that's both the bull and the bear scenario. we should point out that elon musk has proven the bears unbelievably wrong in the last couple years. he's been through a lot of stuff. as you know, he had a brush with the s.e.c. for saying he was going to take the company private. he didn't. he set a price at $420 a share. it's triple that or something close to that right now. remember, the stock price now is a split adjusted stock price. it doesn't -- the 420 was before the stock split. so there's your bull and bear scenario. i can tell you that, you know, he's expanding -- i heard the china expansion is pretty amazing.
the company is talking that up, when analysts and bankers, as they probably should, they think it's a big market over there. and they are ramping up their production in china. back to you. liz: right. and again, don't ignore the battery aspect of this giga berlin is building up and elon is very excited about that. okay. we will be watching it, charlie. so yeah, people, you are being told that monday's the big day. no, no, no. tomorrow is the day where those who have s&p funds that mimic what the s&p is doing have to make sure that they buy the exact amount, exact number of shares of tesla to reflect the weighting. charlie, good on you. thank you very much. cybersecurity experts are warning that that solarwinds hack may just be the tip of the iceberg. but wait until you hear the password that was supposedly protecting our nation's top federal agencies and why our "countdown" closer is putting cybersecurity names at the top of his holiday list.
and i don't think solarwinds is on that list. all right. the closing bell ringing in eight minutes. the dow, s&p, nasdaq and the russell all on track to close at records in just seven and a half minutes. your daily dashboard from fidelity -- a visual snapshot of your investments, key portfolio events, all in one place. because when it's decision time, you need decision tech. only from fidelity. . .
i'm still on the road to what's next. and i'm still going for my best. even though i live with a higher risk of stroke due to afib not caused by a heart valve problem. so if there's a better treatment than warfarin, i'm on top of that. eliquis. eliquis is proven to reduce stroke risk better than warfarin. plus has significantly less major bleeding than warfarin. eliquis is fda-approved and has both. what's next? getting out there. don't stop taking eliquis unless your doctor tells you to, as stopping increases your risk of having a stroke. eliquis can cause serious and in rare cases fatal bleeding. don't take eliquis if you have an artificial heart valve or abnormal bleeding. while taking eliquis, you may bruise more easily and it may take longer than usual for any bleeding to stop. seek immediate medical care for sudden signs of bleeding, like unusual bruising. eliquis may increase your bleeding risk if you take certain medicines. tell your doctor about all planned medical or dental procedures. ask your doctor about eliquis.
and if your ability to afford your medication has changed, we want to help. - any idea how much it will cost? - [doctor] i recommend goodrx. you get free coupons to save on your prescriptions. - goodrx, smart. - [announcer] stop paying too much for your prescriptions. - thanks. - download the free app today. now every bath fitter bathbath fis installed quickly, safely, and beautifully, with a lifetime warranty. go from old to new.
from worn to wow. the beautiful bath you've always wanted, done right, installed by one expert technician, all in one day. we've been creating moments like these for 35 years, and we're here to help you get started. book your free virtual or in-home design consultation today. ♪. liz: four minutes until the closing bell rings. bitcoin is not the only thing enjoying a early santa claus rally. the dow, s&p, nasdaq about to rack up new record closes about to rewrite the pages of history again. fedex reports earnings after the bell. a couple of things investors are watching closely, number one, the christmas packaging season, number two, whether fedex will talk about vaccine distribution in the forward guidance.
ashley webster looking into this. ash? ashley: that vaccine comment will be much listened to because it is growing on right now. yes we're in the middle of the holiday shopping and shipping season. we have lots to consider when they report after the bell. the stock is up 93% year-to-date. trading near a 52 week high. they had a strong performance in the last quarter helping to overcome any set baucussed from the partnership with amazon. can it deliver again? we're looking for earnings around $4.01 per share on revenue of 19.46 billion. yes, liz, we're waiting what whe company says about shipping that vaccine and what it will do for bottom line. increased volumes of freight, airfreight in particular are not going away as well as improvements on profits coming from its ground shipments. you know the analysts are
generally very bullish at ups who upgraded the price target prior to today's earnings to a street high mark of 380 bucks. we'll find out in just a few minutes from now fedex is doing, liz? liz: it is fascinating, ups the big competitor also moving higher today has had a jump of 49% year-to-date. ashley: yep. connell: as we watch the two names, isn't it fascinating ashley it the story is not just moderna, pfizer, j&j involved in the vaccine but the shippers as well. ashley: it is. they have a huge task on their hands not only because we know the pandemic pushed everything online. they're already under stress there but a report came out today there, the on-time shipping records of both fedex and ups are doing very, very well in the mid 95% or thereabouts. ups much more improved over
years past. that is positive for both the companies, face it logistically have been under stress for quite some time but it bodes well for this reporting quarter as well in the very busy shipping season we should say. so it is good for both companies. connell: indeed. ashley thank you very much. ashley webster. ashley: my pleasure. liz: we're talking about the solar winds hack where they were able to access the treasury department, commerce department in a widespread hack. who is they? possibly the russians. you know how they tell you to make the passwords gibberish so no one guesses them. this was server password choice. are you ready for this, solarwinds 1223. 123. that was the password,
solarwinds123. a security expert warned the company about the password before the hack happened. that is company that got hammered. it is moving at the moment. [closing bell rings] down another 2 1/3%. up, dow, s&p, nasdaq and the russell appear to be closing at record highs. time for "after the bell." connell: we're at all-time highs here. stocks riding high on the vaccine rollout. stimulus optimism. an fda panel is meeting to decide to approve moderna vaccine for emergency use. if approved it would be the second vaccine approved in the u.s. hype pfizer. on capitol hill we do have lawmakers getting close on a 900 billion-dollar stimulus. you put that all